https://orcid.org/0000-0002-9720-5904
References
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. DOI:https://doi.org/10.3322/caac.21660
- Mattiuzzi C, Sanchis-Gomar F, Lippi G. Concise update on colorectal cancer epidemiology. Ann Transl Med. 2019;7:609.
- Xiang T, Fan Y, Li C, et al. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells. Oncotarget. 2016;7:70924.
- Yuan G, Wang C, Ma C, et al. Oncogenic function of DACT1 in colon cancer through the regulation of β-catenin. PloS One. 2012;7:e34004.
- Hou J, Wen Y-H, Feng K-N, et al. DACT1 is involved in human placenta development by promoting Wnt signaling. Arch Gynecol Obstet. 2015;291:1289–1296.
- Li R-N, Liu B, Li X-M, et al. DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy. Sci Rep. 2017;7:9285.
- Huang C, Wang Y, Fan H, et al. Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study. Onco Targets Ther. 2016;9:5975.
- Cheng X, Xu X, Chen D, et al. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 2019;110:473–481.
- Frank B, Hoffmeister M, Klopp N, et al. Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis. 2010;31:1381–1386.
- Fernandez-Rozadilla C, De Castro L, Clofent J, et al. Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort. PLoS One. 2010;5:e12673.
- Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011;12:683.
- Fernández-Calero T, Cabrera-Cabrera F, Ehrlich R, et al. Silent polymorphisms: can the tRNA population explain changes in protein properties? Life. 2016;6:9.
- Sun X, Feng Z, Wang Y, et al. Expression of Foxp3 and its prognostic significance in colorectal cancer. Int J Immunopathol Pharmacol. 2017;30:201–206.
- Wu D, Tang R, Qi Q, et al. Five functional polymorphisms of B7/CD28 co-signaling molecules alter susceptibility to colorectal cancer. Cell Immunol. 2015;293:41–48.
- Kriegl L, Horst D, Reiche JA, et al. LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. J Transl Med. 2010;8:123.